Prevalencia del cáncer de próstata en lesiones hipoecoicas de la ecografía transrectal de próstata

Vista sencilla de ítem
dc.contributor.advisorDe La Hoz, José Antonio
dc.contributor.authorHernández Torres, Sebastián Juan
dc.contributor.authorPáez Alarcón, Marco Antonio
dc.coverage.spatialHospital Simon Bolivarspa
dc.coverage.temporal1-02-2020 - 01-03-2020spa
dc.date.accessioned2020-08-03T21:32:49Z
dc.date.available2020-08-03T21:32:49Z
dc.date.issued2020
dc.description.abstractResumen Objetivo: Determinar la prevalencia del cáncer de próstata en las lesiones hipoecoicas evidenciadas durante la toma de las biopsias de próstatas dirigida por ecografía transrectal. Materiales y métodos: El estudio se realizó retrospectivamente analizando datos de 223 pacientes llevados a biopsia transrectal de próstata. Los hallazgos anatomopatológicos de la biopsia, nivel de antígeno prostático especifico pre biopsia, puntaje Gleason y otras variables clínicas se compararon entre pacientes con cáncer de próstata con lesiones hipoecoicas y sin estas. Resultados: Se observó cáncer de próstata en 67 de los 223 pacientes (30%). La tasa de detección de cáncer fue mayor en pacientes con lesiones hipoecoicas (61.5%) que en aquellos sin lesiones hipoecoicas (20.5%). P = <0.000. El cáncer de próstata se detectó con mayor frecuencia en pacientes con lesiones hipoecoicas multifocales (80%) que en aquellos con lesiones hipoecoicas unifocales (48.6%) (p ＜ 0.001), la zona con mayor afectación como era de esperar fue la zona periférica. Adicionalmente también hubo una mayor detección de cáncer de próstata en pacientes con antígeno específico prostático > 10 ng/ml (41.4%) en comparación con aquellos ≤ 10 ng/ml (18.9%). P= < 0.000. Conclusiones: Los pacientes en los que se observó lesiones hipoecoicas, tenían una mayor prevalencia de cáncer de próstata en comparación con aquellos que presentaban ecografía transrectal normal. Por lo tanto, las lesiones hipoecoicas pueden ser un marcador de cáncer de próstata, así como de enfermedad clínicamente significativa. Palabras claves: cáncer, próstata, nódulo hipoecoico, biopsia, transrectal.spa
dc.description.abstractenglishObjective: to determine the prevalence of prostate cancer in hypoechoic lesions evidenced during the taking of prostate biopsies conducted by transrectal ultrasound. Materials and methods: The study was performed retrospectively analyzing data from 223 patients undergoing a transrectal prostate biopsy. Pathologic findings from biopsy, pre-biopsy prostate-specific antigen level, Gleason score, and other clinical variables were compared between prostate cancer patients with and without hypoechoic lesions. Results: Prostate cancer was suffered in 67 of the 223 patients (30%). The cancer detection rate was higher in patients with hypoechoic lesions (61.5%) than in those without hypoechoic lesions (20.5%). P = <0.000. Prostate cancer is detected more frequently in patients with multifocal hypoechoic lesions (80%) than in those with unifocal hypoechoic lesions (48.6%) (p ＜ 0.001), the area with the greatest involvement as expected was the peripheral area. Furthermore, there was also a higher detection of prostate cancer in patients with prostate specific antigen> 10 ng / ml (41.4%) compared to those ≤ 10 ng / ml (18.9%). P = <0.000. Conclusions: Patients with hypoechoic lesions have a higher prevalence of prostate cancer compared to those with normal transrectal ultrasound. Therefore, hypoechoic lesions can be a marker of prostate cancer, as well as clinically significant disease. Palabras claves: cáncer, próstata, nódulo hipoecoico, biopsia, transrectal. Key words: cancer, prostate, hypoechoic nodule, biopsy, transrectal.eng
dc.description.degreelevelEspecializaciónspa
dc.description.degreenameEspecialista en Urologíaspa
dc.description.sponsorshipHospital Simon Bolivarspa
dc.format.mimetypeapplication/pdf
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/3654
dc.language.isospa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.grantorUniversidad El Bosquespa
dc.publisher.programEspecialización en Urologíaspa
dc.relation.references18. Referencias bibliográficas 1. Mottet N, van den Bergh E, Briers P, Cornford M, De Santis S, Fanti S et al. Oncology Guidelines of Prostate Cancer. EAU Annual Congress. Barcelona: European Association of Urology; 2019. p. 978-94. 2. Bell K, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. International Journal of Cancer. 2015;137(7):1749-1757. 3. Jansson K, Akre O, Garmo H, Bill-Axelson A, Adolfsson J, Stattin P et al. Concordance of Tumor Differentiation Among Brothers with Prostate Cancer. European Urology. 2012;62(4):656-661. 4. Smeenge M, Barentsz J, Cosgrove D, de la Rosette J, de Reijke T, Eggener S et al. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. BJU International. 2012;110(7):942-948. 5. Klemann N, Røder M, Helgstrand J, Brasso K, Toft B, Vainer B et al. Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study. The Lancet Oncology. 2017;18(2):221-229. 6. Numao N, Kawakami S, Sakura M, Yoshida S, Koga F, Saito K et al. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU International. 2011;109(5):665-671. 7. Matiz JLP, Reyes NJA, Becerra MPS, Almendrales FPD. Evolución de la mortalidad por cáncer de próstata en Colombia: estudio ecológico. Urología Colombiana 2014 Apr;23(1):3-10. 8. Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E et al. Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-guided In-bore Biopsy to MRI-ultrasound Fusion and Transrectal Ultrasound-guided Prostate Biopsy in Patients with Prior Negative Biopsies. European Urology. 2015;68(4):713-720. 9. Schröder F, van den Bergh R, Wolters T, van Leeuwen P, Bangma C, van der Kwast T et al. Eleven-Year Outcome of Patients with Prostate Cancers Diagnosed During Screening After Initial Negative Sextant Biopsies. European Urology. 2010;57(2):256-266. 10. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386. 11. Dickerman B, Markt S, Koskenvuo M, Pukkala E, Mucci L, Kaprio J. Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins. Cancer Causes & Control. 2016;27(9):1049-1058. 12. Zhao J, Stockwell T, Roemer A, Chikritzhs T. Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta–analysis. BMC Cancer. 2016;16(1). 13. Lopes P, Sepúlveda L, Ramos R, Sousa P. The role of transrectal ultrasound in the diagnosis of prostate cancer: new contributions. Radiologia Brasileira. 2015;48(1):7-11. 14. Ganie F, Wanie M, Ganie S, Lone H, Gani M, Mir M et al. Correlation of transrectal ultrasonographic findings with histo pathology in prostatic cancer. Jornal of Education and Health promotion. 2014;3(38). 15. Zhao H, Xia C, Yin H, Guo N, Zhu Q. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer. European Journal of Radiology. 2013;82(11):e641-e647. 16. Zhao H, Zhu Q, Wang Z. Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results. The British Journal of Radiology. 2012;85(1014):714-719. 17.Loch T. Computergestützter transrektaler Ultraschall (C-TRUS) in der Diagnostik des Prostatakarzinoms. Der Urologe, Ausgabe A. 2004;43(11):1377-1384. 18.Shinohara K, Wheeler TM, Scardino PT. The Appearance of Prostate Cancer on Transrectal Ultrasonography: Correlation of Imaging and Pathological Examinations. The Journal of urology. 1989;142(1):76-82. 19.Lojanapiwat B, Anutrakulchai W, Chongruksut W, Udomphot C. Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice. Prostate International. 2014;2(3):133-139. 20.Trabulsi E, Halpern E, Gomella L. Prostate Biopsy: Techniques and Imaging. In: Campbell, Walsh, ed. by. Urology. 11th ed. 2020. p. 3490-3505. 21.Babinski M, Chagas M, Costa W, Pereira M. Morfología y fracción del área del lumen glandular de la zona de transición de la próstata humana. 2020.p.255-262. 22.Cancer Facts & Figures 2017 [Internet]. Cancer.org. 2017 [cited 11 July 2020]. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html 23.Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013;63(1):11-30. 24. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-07-3. 25.Adhyam M, Gupta A. A Review on the Clinical Utility of PSA in Cancer Prostate. Indian Journal of Surgical Oncology. 2012;3(2):120-129. 26.Wolf A, Wender R, Etzioni R, Thompson I, D'Amico A, Volk R et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA: A Cancer Journal for Clinicians. 2010;60(2):70-98. 27.Freedland S, Hotaling J, Fitzsimons N, Presti J, Kane C, Terris M et al. PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database. European Urology. 2008;53(4):758-766. 28.Walsh A, Considine S, Thomas A, Lynch T, Manecksha R. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study. British Journal of General Practice. 2014;64(629):e783-e787. 29.Issa M, Zasada W, Ward K, Hall J, Petros J, Ritenour C et al. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy. Cancer Detection and Prevention. 2006;30(3):269-275. 30. 14. Herranz Amo F, Díez Cordero J, Cabello Benavente R. Evolución de la técnica de biopsia transrectal ecodirigida de la próstata [Internet]. Scielo.isciii.es. 2020;59(4):385-396. 31.Miller D, Hafez K, Stewart A. Prostate carcinoma presentation, diagnosis and staging. An update from the national cancer database. Cancer. 2003;(98). 32.de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hoznek A et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology. 2003;61(6):1181-1186. 33.Taneja S, Bjurlin M, Carter B. Optimal Techniques of Prostate Biopsy and Specimen Handling. American Urological Association. 2020. 34. Hodge K, McNeal J, Terris M, Stamey T. Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the Prostate. Journal of Urology. 1989;142(1):71-74. 35. Herranz F, Arias F, Arrizabalaga M, Calahorra F, Carballido J, Diz R. El cancer de prostata en la comunidad de Madrid en el año 2000. Actas Urologicas Españolas. 2003;27(5):335-344. 36.Noh T, Shin Y, Shim J, Yoon J, Kim J, Bae J et al. Are Hypoechoic Lesions on Transrectal Ultrasonography a Marker for Clinically Significant Prostate Cancer?. Korean Journal of Urology. 2013;54(10):666. 37.Sonn G, Chang E, Natarajan S, Margolis D, Macairan M, Lieu P et al. Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen. European Urology. 2014;65(4):809-815. 38.Vilanova J, Luna A, Boada M, Barcelo J. Resonancia magnética multiparamétrica. Papel de las técnicas de RM en el diagnóstico, estadiage y seguimiento del cáncer de próstata. Arch Esp Urol. 2015;68(3). 39.EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-07-3 40.Bolaños P, Chacón C. Escala patológica de Gleason para el cáncer de próstata y sus modificaciones. Med leg Costa Rica. 2020;34(1):237-243. 41.Epstein J, Allsbrook W, Amin M, Egevad L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. The American Journal of Surgical Pathology. 2005;29(9):1228-1242. 42.Epstein J, Egevad L, Amin M, Delahunt B, Srigley J, Humphrey P. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. The American Journal of Surgical Pathology. 2015;:1. 43.Epstein J, Walsh P, Sauvageot J, Ballentine Carter H. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. Journal of Urology. 1997;158(5):1886-1890. 44.McNeal. Zonal distribution of prostatic adenocarcinomas: correlation with histologic pattern and direction of spread. J Clin Pathol. 1988;(12). 45.Stamey, Dietrick,. “Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels prostate specific antigen”. Urol. 1993;149. 46.Terris M, Pham T, Kabalin J. Routine Transition Zone and Seminal Vesicle Biopsies in All Patients Undergoing Transrectal Ultrasound Guided Prostate Biopsies Are Not Indicated. Journal of Urology. 2020;157(1):204-206. 47. Bazinet M, Karakiewicz P, Aprikian A, Trudel C, Aronson S, Nachabe M. Value of Systematic Transition Zone Biopsies in the Early Detection of Prostate Cancer. Journal of Urology. 2020;155(2):605. 48.Lui P, Terris M, Stamey T. Indications for Ultrasound Guided Transition Zone Biopsies in the Detection of Prostate Cancer. Journal of Urology. 1995;153(3). 49.Gosselaar C, Roobol MJ, Roemeling S, Wolters T, van Leenders GJ, Schroder FH. The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer. BJU Int. 2008;101:685-90. 50.Noh TI, Shin YS, Shim JS, Yoon JH, Kim JH, Bae JH, et al. Are hypoechoic lesions on transrectal ultrasonography a marker for clinically significant prostate cancer? Korean journal of urology. 2013 Oct;54(10):666-670. 51.Onur R, Littrup PJ, Pontes JE, Bianco FJ Jr. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol. 2004; 172:512–4. 52.Littrup PJ, Bailey SE. Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin North. Am 2000;38:87-113. 53.Wegelin O, van Melick HH, Hooft L, Bosch JL, Reitsma HB, Barentsz JO, Somford DM. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Eur Urol. 2016; 71:517–31.spa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.creativecommons2020-07-31
dc.rights.localAcceso abiertospa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectcáncer, próstata, nódulo hipoecoico, biopsia, transrectal.spa
dc.subject.keywordscancer, prostate, hypoechoic nodule, biopsy, transrectal.spa
dc.subject.nlmWJ100spa
dc.titlePrevalencia del cáncer de próstata en lesiones hipoecoicas de la ecografía transrectal de próstataspa
dc.title.translatedPrevalence of prostate cancer in hypoechoic lesions from transrectal prostate ultrasoundspa
dc.type.coarhttps://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttps://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driverinfo:eu-repo/semantics/bachelorThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesis/Trabajo de grado - Monografía - Especializaciónspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
TESIS UROLOGÍA 2020.pdf
Tamaño:
730.55 KB
Formato:
Adobe Portable Document Format
Descripción:
Prevalencia del cáncer de próstata en lesiones hipoecoicas de la ecografía transrectal de próstata
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Especialización en Urología